From Recipe to Dinner: Business Model Portfolios in the European Biopharmaceutical Industry

Teece, 2010, Business model, business strategy and Innovation, Long Range Planning, 43, 172, 10.1016/j.lrp.2009.07.003 Baden, 2010, Fuller and M. Morgan, Business models as models, Long Range Planning, 43, 156, 10.1016/j.lrp.2010.02.005 Mowery, 2001, The growth of patenting and licensing by U.S. Universities: An assessment of the effect of the Bayh-Dole act of 1980, Research Policy, 30, 99, 10.1016/S0048-7333(99)00100-6 Hopkins, 2007, The myth of biotech revolution: An assessment of technological, clinical and organisational change, Research Policy, 36, 566, 10.1016/j.respol.2007.02.013 Rothman, 2006, Downstream and into deep biology: Evolving business models in ‘top tier’ genomics companies, Journal of Commercial Biotechnology, 12, 86, 10.1057/palgrave.jcb.3040154 M. M. Hopkins P. A. Martin P. Nightingale A. Kraft and S. Mahdi (2007) op. cit. at Ref. 3. A. Gambardella and A. M. McGahan, Business-model innovation: General purpose technologies and their implications for industry architecture, Long Range Planning 43(2–3), 262–271 (2010). Morris, 2005, The entrepreneur's business model: Toward a unified perspective, Journal of Business Research, 58, 726, 10.1016/j.jbusres.2003.11.001 Voelpel, 2004, The Wheel of business model reinvention: How to reshape your business model to leagfrog competitors, Journal of Change Management, 4, 259, 10.1080/1469701042000212669 Hunter, 2006, Low cost airlines: business model and employment relations, European Management Journal, 24, 315, 10.1016/j.emj.2006.08.001 Magretta, 2002, Why Business Models Matter, Harvard business review, 80, 86 Chesbrough, 2002, The role of business model in capturing value from innovation: Evidences from Xerocs Corporation's technology spin-off companies, Industrial and Corporate Change, 11, 529, 10.1093/icc/11.3.529 A. Gambardella and A. M. McGahan (2010), op. cit. at Ref. 6. Mangematin, 2003, Sectoral system of innovation, SMEs development and heterogeneity of trajectories, Research Policy, 32, 621, 10.1016/S0048-7333(02)00045-8 Casper, 2007, How do technology clusters emerge and become sustainable? Social network formation and inter-firm mobility within the San Diego biotechnology cluster, Research Policy, 36, 438, 10.1016/j.respol.2007.02.018 Zott, 2010, Amit, Business model design: an activity system perspective, Long Range Planning, 43, 216, 10.1016/j.lrp.2009.07.004 DiMasi, 2003, The price of innovation: new estimates of drug development costs, Journal of Health Economics, 22, 151, 10.1016/S0167-6296(02)00126-1 Gittelman, 2003, Does good science lead to valuable knowledge? Biotechnology firms and the evolutionary logic of citation patterns, Management Science, 49, 366, 10.1287/mnsc.49.4.366.14420 McNamara, 2007, Shareholder returns and the exploration–exploitation dilemma: R&D announcements by biotechnology firms, Research Policy, 36, 548, 10.1016/j.respol.2007.02.012 Afuah, 1997, Responding to Structural Industry Changes: A Technological Evolution Perspective, Industrial and Corporate Change, 6, 183, 10.1093/icc/6.1.183 Pettigrew, 1990, Longitudinal field research on change: theory and practice, Organization Science, 1, 10.1287/orsc.1.3.267 J. J Zhang and C. Baden Fuller Brokerage and firm network evolution: The Complementary Roles of Architectural and Functional Brokers, Cass Working Paper (2008). Schweizer, 2005, Concept and evolution of business models, Journal of General Management, 31, 37, 10.1177/030630700503100203